DUBLIN–(BUSINESS WIRE)–The “Global DNA Vaccines Market (2022-2027) by Product Type, Type, End-User Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global DNA Vaccines Market is estimated to be USD 477.65 Mn in 2022 and is projected to reach USD 646.47 Mn by 2027, growing at a CAGR of 6.24%.
Market Segmentations
The Global DNA Vaccines Market is segmented based on Product Type, Type, End Userand Geography.
- By Product Type, the market is classified into Oncept, West Nile-Innovator, and West Nile-Innovator.
- By Type, the market is classified into Therapeutic Vaccines and Prophylactic Vaccines.
- By End User, the market is classified into Veterinary Clinics, and Veterinary Hospitals.
- By Geography, the market is classified into Americas, Europe, Middle-East & Africa and Asia-Pacific.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are AstraZeneca, Eli-Lilly (Novartis Animal Health), Bristol-Myers Squibb, Geovax Labs, Inovio Pharmaceuticals (Vgx Animal Health), Genexine, Viatris (Rottapharm Biotech), Gilead Sciences, Zoetis (Fort Dodge Animal Health), Johnson & Johnson, Merck, Pfizer, Sanofi-Aventis, etc.
Countries Studied
- America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
- Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
- Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
- Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.
Ansoff Analysis
- The report presents a detailed Ansoff matrix analysis for the Global DNA Vaccines Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.
- The report analyses the Global DNA Vaccines Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.
- Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.
Market Dynamics
Drivers
- Rise in Prevalence of Cancer and Infectious Diseases in Humans and Animals
- Increase in Demand for DNA Vaccines
- Growth in Number of Antibiotic Resistant Pathogens
Restraints
- Lack of Immunogenicity Associated with DNA Vaccines
- Limited Knowledge about the Effects Of DNA Vaccines On Humans
Opportunities
- Development Of Novel Vaccines Using DNA Technology
- High Growth Potential In Untapped Emerging Economies
Challenges
- Lengthy Development and Approval Process
Key Topics Covered:
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Dynamics
5 Market Analysis
6 Global DNA Vaccines Market, By Product Type
7 Global DNA Vaccines Market, By Type
8 Global DNA Vaccines Market, By End User
9 Americas’ DNA Vaccines Market
10 Europe’s DNA Vaccines Market
11 Middle East and Africa’s DNA Vaccines Market
12 APAC’s DNA Vaccines Market
13 Competitive Landscape
14 Company Profiles
15 Appendix
Companies Mentioned
- AstraZeneca
- Eli-Lilly (Novartis Animal Health)
- Bristol-Myers Squibb
- Geovax Labs
- Inovio Pharmaceuticals (Vgx Animal Health)
- Genexine
- Viatris (Rottapharm Biotech)
- Gilead Sciences
- Zoetis (Fort Dodge Animal Health)
- Johnson & Johnson
- Merck
- Pfizer
- Sanofi-Aventis
For more information about this report visit https://www.researchandmarkets.com/r/23jnwk
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
